Skip to main content
. 2023 Mar 16;146(9):3816–3825. doi: 10.1093/brain/awad089

Table 1.

Management and treatment of adults with viral meningitis

Management and treatment All viral meningitis Confirmed viral meningitis EVs HSV-2 VSV Miscellaneous viruses Unidentified pathogen
n = 1066 n = 783 n = 419 n = 171 n = 162 n = 31 n = 283
CNS infection as the referral diagnosis 435/917 (47) 354/703 (50) 220/401 (55) 82/149 (55) 42/126 (33) 10/27 (37) 81/214 (38)
Direct admission to a department of ID 474/1065 (45) 372/782 (48) 221/419 (53) 85/170 (50) 63/162 (39) 13/31 (42) 102/283 (36)
Time until lumbar puncture, h 3.0 (1.3–7.1) 2.7 (1.2–6.3) 2.2 (1.0–4.7) 1.9 (1.0–4.7) 6.2 (2.1–17.8) 4.4 (2.0–15.9) 4.3 (2.0–11.0)
CSF culture 985/1066 (92) 732/783 (93) 400/419 (95) 155/171 (91) 148/162 (91) 29/31 (94) 253/283 (89)
CSF PCR for EVs/HSV/VZV 1054/1066 (99) 779/783 (99) 419/419 (100) 169/171 (99) 162/162 (100) 29/31 (94) 275/283 (97)
ITS of antibodies for HSV/VZV 240/1066 (23) 167/783 (21) 74/419 (18) 41/171 (24) 43/162 (27) 9/31 (29) 73/283 (26)
Blood culture 781/1055 (74) 591/775 (76) 344/419 (82) 135/170 (79) 89/157 (57) 23/29 (79) 190/280 (68)
Brain imaging 544/1066 (51) 356/783 (45) 168/419 (40) 69/171 (40) 100/162 (62) 19/31 (61) 188/283 (66)
Brain imaging prior to lumbar puncture 408/1058 (39) 270/780 (35) 142/418 (34) 48/171 (28) 69/161 (43) 11/30 (37) 138/278 (50)
Acyclovir or valacyclovir 743/1060 (70) 552/782 (71) 215/418 (51) 163/171 (95) 158/162 (98) 16/31 (52) 191/278 (69)
Antibiotics for bacterial meningitis 504/1058 (48) 365/776 (47) 212/415 (51) 96/171 (56) 44/161 (27) 13/29 (45) 139/281 (49)
Dexamethasone for bacterial meningitis 380/1062 (36) 283/780 (36) 168/418 (40) 78/171 (46) 27/162 (17) 10/29 (34) 97/282 (34)
Length of hospitalization, days 3 (1–5) 2 (1–4) 2 (1–2) 3 (2–6) 5 (3–11) 5 (3–8) 4 (2–6)

Quantitative data are presented as median (IQR) and categorical data are presented as n/N (%). ID = infectious diseases; ITS = intrathecal synthesis.